万元童颜针降至999元背后:供需反转,医美企业向供应商要回定价权

第一财经
Feb 04

上游医美供应链厂商单纯依靠控价维持高利润的时代或许一去不复返了。  近日,新氧宣布与索塔、艾尔建、爱美客、华熙生物、锦波生物、四环医药等首批14家上游厂商达成合作。  其中,不少企业曾与新氧围绕着定价的问题闹得不可开交,供应商甚至一度断供。不过,目前看来。这场贯穿了去年整年的定价权大战随着此次合作的达成摁下了暂停键。  在不少行业人士看来,这背后折射出医美行业上下游力量的重构,也预示着整个行业发展...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10